Through our
Premium quality pharmaceuticals
We enable patients to live a better quality of life
Read More
0
0
0Corporate Video
Hyphens Pharma is a part of the Hyphens Group. Watch it to get a quick overview of what Hyphens Group is about.
Latest news
Hyphens Pharma is exclusive distributor of Wynzora® Cream in Southeast Asia
Hyphens Pharma has been awarded exclusive rights by MC2 Therapeutics to commercialise and supply Wynzora® Cream and all future product extensions throughout ASEAN. Wynzora® Cream is a leading topical treatment for plaque and scalp psoriasis in adults, currently marketed in Italy, Germany, Spain, United Kingdom and United States. Read more here.
Hyphens Pharma has been awarded exclusive rights by MC2 Therapeutics to commercialise and supply Wynzora® Cream and all future product extensions throughout ASEAN. Wynzora® Cream is a leading topical treatment for plaque and scalp psoriasis in adults, currently marketed in Italy, Germany, Spain, United Kingdom and United States. Read more here.
Hyphens Pharma brings Ceradan® to the Middle East
February 2024 – In partnership with Cooper Pharma, Hyphens Pharma’s flagship dermatological brand, Ceradan®, is poised to bring relief to eczema suffers in the Middle East, including Saudi Arabia, United Arab Emirates, Kuwait, Qatar and Bahrain. Click here to read the full story.
February 2024 – In partnership with Cooper Pharma, Hyphens Pharma’s flagship dermatological brand, Ceradan®, is poised to bring relief to eczema suffers in the Middle East, including Saudi Arabia, United Arab Emirates, Kuwait, Qatar and Bahrain. Click here to read the full story.